Effects of low dose lithium on hippocampal neuropathology in people at ultra-high risk for psychosis

Autor: Wood, Stephen J., Berger, Gregor, Dell'Ollio, Margaret, Hamer, Clare A., Wellard, R. Mark, Pell, Gaby S., Phillips, L. J., Nelson, Barnaby, Manji, Husseini, Jackson, Graeme J., Pantelis, Christos, McGorry, Patrick D.
Rok vydání: 2007
Předmět:
060104 Cell Metabolism
110000 MEDICAL AND HEALTH SCIENCES
MRS
hippocamus
110903 Central Nervous System
170112 Sensory Processes Perception and Performance
111601 Cell Physiology
170000 PSYCHOLOGY AND COGNITIVE SCIENCES
psychosis
111603 Systems Physiology
060100 BIOCHEMISTRY AND CELL BIOLOGY
110904 Neurology and Neuromuscular Diseases
110902 Cellular Nervous System
110900 NEUROSCIENCES
100499 Medical Biotechnology not elsewhere classified
MR spectroscopy
170100 PSYCHOLOGY
110199 Medical Biochemistry and Metabolomics not elsewhere classified
111600 MEDICAL PHYSIOLOGY
110100 MEDICAL BIOCHEMISTRY AND METABOLOMICS
060000 BIOLOGICAL SCIENCES
litium
170200 COGNITIVE SCIENCE
170101 Biological Psychology (Neuropsychology Psychopharmacology Physiological Psychology)
170205 Neurocognitive Patterns and Neural Networks
060105 Cell Neurochemistry
060602 Animal Physiology - Cell
neuropathy
Zdroj: Biological Psychiatry
ISSN: 2381-3652
Popis: Background: Indicated intervention prior to the onset of psychosis may help to delay, attenuate or even prevent the illness. To date, successful intervention trials using atypical antipsychotics and/or cognitive behavioural therapy have been reported, but it is not clear that these treatments are targeting the underlying brain pathology. Given our previous findings of progressive grey matter loss over the transition to psychosis, agents that can prevent this, such as lithium, might be useful for preventing or delaying the onset of psychosis. Methods: In this open-label trial, 11 ultra-high-risk patients who received low- dose lithium treatment for four months were compared with 10 similar patients who received only needs-based intervention. Magnetic resonance imaging, including T2 relaxometry and proton spectroscopy was performed prior to initiation of treatment and after four months. Results: Hippocampal T2 declined significantly in the treatment group (p=0.018). No significant group x time effects were seen for brain metabolites, although N-acetyl aspartate (NAA), myo-inositol, creatine and choline all tended to increase with lithium administration and decrease or remain unchanged in the comparison group. Conclusions: Decreased T2 relaxation time and increased concentrations of NAA are indicators of increased neuronal function/viability. Low-dose lithium may help regulate synaptic pruning and reduce neuronal dysfunction associated with the onset of psychosis.
Databáze: OpenAIRE